E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/18/2010 in the Prospect News PIPE Daily.

iBio settles $8 million placement of stock with $1.94 million tranche

Fully subscribed deal consists of 4 million shares sold at $2.00 each

By Devika Patel

Knoxville, Tenn., Nov. 18 - iBio, Inc. said it completed a fully subscribed private placement of stock. The company raised $6.07 million on Oct. 27 for a total of $8 million.

The company sold 3,032,500 common shares at $2.00 apiece in the first tranche and 967,500 shares in the second for $1.94 million. It sold a total of 4 million shares. The price per share is a 4.76% discount to $2.10, the Oct. 26 closing share price.

Investors also received 100% warrant coverage. Each five-year warrant is exercisable at $2.20, a 4.76% premium to the Oct. 26 closing price.

"It's always good to get these sorts of things finished," Robert Erwin, president of iBio, told Prospect News. "We have had a lot of interest."

Erwin said many interested investors were those with previous biotechnology experience, though he added that some others - including retail investors - were trying to get in on the game.

"Our trading volume has slowly increased over the last few months," he noted, opining that it was due in part to retail interest.

Erwin said the financing was part of "the normal cycle of raising money" and that proceeds would be used to "fund ongoing development and normal corporate operations.

"This is going to be plenty of money to last us for quite a while," he added, though he said that as a biotech company "we always like to stay in touch with the market" and that if a good opportunity presented itself, it would be considered.

Noble Financial Capital Markets was the agent.

The biotechnology company is based in Newark, Del.

Stephanie N. Rotondo contributed to this article

Issuer:iBio, Inc.
Issue:Common stock
Amount:$8 million
Shares:4 million
Price:$2.00
Warrants:100% coverage
Warrant expiration:Five years
Warrant strike price:$2.20
Agent:Noble Financial Capital Markets
Settlement date:Oct. 27 (for $6,065,000), Nov. 18 (for $1,935,000)
Stock symbol:OTCBB: IBPM
Stock price:$2.16 at close Oct. 27
Market capitalization:$84.82 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.